J0891 HCPCS Level II code: Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
J0891 is the HCPCS code for “Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
Short description: Argatroban nonesrd (accord)
HCPCS · United States
Medicare details
The indicators CMS publishes with J0891 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Other medical items or services
- BETOS category
- Other drugs
- Added
- Jan 1, 2023
Where J0891 sits
- 1J codesDrugs administered other than orally
- 2Active code J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0891 mean?
J0891 is the HCPCS code for “Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0891?
CMS lists J0891’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0891
All J codesJ0885Injection, epoetin alfa, (for non-esrd use), 1000 unitsJ0886Injection, epoetin alfa, 1000 units (for esrd on dialysis)J0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)J0888Injection, epoetin beta, 1 microgram, (for non esrd use)J0889Daprodustat, oral, 1 mg, (for esrd on dialysis)J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mgJ0894Injection, decitabine, 1 mgJ0895Injection, deferoxamine mesylate, 500 mgJ0896Injection, luspatercept-aamt, 0.25 mgJ0897Injection, denosumab, 1 mg